Th - tyrosine hydroxylase Gene

Also Known as The

Species: Rattus norvegicus

Gene Type: protein coding
Gene ID: 25085

Summary

Enables several functions, including cation binding activity; tetrahydrobiopterin binding activity; and tyrosine 3-monooxygenase activity. Involved in several processes, including aminergic neurotransmitter loading into synaptic vesicle; carboxylic acid metabolic process; and cellular response to nicotine. Located in several cellular components, including cytoplasmic vesicle; perikaryon; and terminal bouton. Used to study Parkinson's disease. Biomarker of several diseases, including brain disease (multiple); hyperprolactinemia; hypoglycemia; polycystic ovary syndrome; and portal hypertension. Human ortholog(s) of this gene implicated in Parkinson's disease; Parkinsonism; hypertension; and obesity. Orthologous to human TH (Tyrosine Hydroxylase). [provided by Alliance of Genome Resources, Apr 2022]

Th Products (1)

mRNA Protein Name
NM_012740.4 NP_036872.1 tyrosine 3-monooxygenase

Gene Ontology

  • Molecular Function
  • Biological Process
  • Cellular Component
Molecular Function GO Annotation Evidence References Source
enables amino acid binding IDA
IDA: Inferred from direct assay
19489646 RGD
enables amino acid binding IPI
IPI: Inferred from physical interaction
15639226 RGD
enables dopamine binding IPI
IPI: Inferred from physical interaction
15639226 RGD
enables ferric iron binding IDA
IDA: Inferred from direct assay
16475826 RGD
enables ferrous iron binding IDA
IDA: Inferred from direct assay
16475826 RGD
enables monooxygenase activity IDA
IDA: Inferred from direct assay
33381 RGD
enables oxygen binding IDA
IDA: Inferred from direct assay
19489646 RGD
enables protein binding IPI
IPI: Inferred from physical interaction
11943812 RGD
enables protein domain specific binding IPI
IPI: Inferred from physical interaction
19903816 RGD
enables small molecule binding EXP
EXP: Inferred from Experiment
19371093 RGD
enables small molecule binding IDA
IDA: Inferred from direct assay
10375411 RGD
enables tetrahydrobiopterin binding IDA
IDA: Inferred from direct assay
19489646 RGD
enables tyrosine 3-monooxygenase activity IDA
IDA: Inferred from direct assay
19489646 RGD
Biological Process GO Annotation Evidence References Source
involved in aminergic neurotransmitter loading into synaptic vesicle IDA
IDA: Inferred from direct assay
19903816 RGD
involved in catecholamine biosynthetic process IDA
IDA: Inferred from direct assay
20025246 RGD
involved in cellular response to alkaloid IEP
IEP: Inferred from expression pattern
18696327 RGD
involved in cellular response to glucose stimulus IEP
IEP: Inferred from expression pattern
21217063 RGD
involved in cellular response to growth factor stimulus IEP
IEP: Inferred from expression pattern
17306206 RGD
involved in cellular response to manganese ion IEP
IEP: Inferred from expression pattern
19781568 RGD
involved in cellular response to nicotine IEP
IEP: Inferred from expression pattern
20827341 RGD
involved in cellular response to xenobiotic stimulus IEP
IEP: Inferred from expression pattern
18602388 RGD
involved in cerebral cortex development IEP
IEP: Inferred from expression pattern
21295554 RGD
involved in circadian sleep/wake cycle IEP
IEP: Inferred from expression pattern
20980612 RGD
involved in cognition IEP
IEP: Inferred from expression pattern
20096955 RGD
involved in dopamine biosynthetic process from tyrosine IDA
IDA: Inferred from direct assay
2427363 RGD
involved in dopamine biosynthetic process from tyrosine IMP
IMP: Inferred from mutant phenotype
11943812 RGD
involved in fatty acid metabolic process IEP
IEP: Inferred from expression pattern
21071351 RGD
involved in glycoside metabolic process IEP
IEP: Inferred from expression pattern
20183248 RGD
involved in heart development IDA
IDA: Inferred from direct assay
21280046 RGD
involved in isoquinoline alkaloid metabolic process IEP
IEP: Inferred from expression pattern
18305432 RGD
involved in phthalate metabolic process IEP
IEP: Inferred from expression pattern
21145954 RGD
involved in phytoalexin metabolic process IEP
IEP: Inferred from expression pattern
19185027 RGD
involved in response to activity IEP
IEP: Inferred from expression pattern
21276429 RGD
involved in response to amphetamine IEP
IEP: Inferred from expression pattern
21078367 RGD
involved in response to corticosterone IEP
IEP: Inferred from expression pattern
19494803 RGD
involved in response to electrical stimulus IEP
IEP: Inferred from expression pattern
21296669 RGD
involved in response to estradiol IEP
IEP: Inferred from expression pattern
11914591 RGD
involved in response to ethanol IEP
IEP: Inferred from expression pattern
16713504 RGD
involved in response to ether IEP
IEP: Inferred from expression pattern
15896472 RGD
involved in response to growth factor IEP
IEP: Inferred from expression pattern
21236244 RGD
involved in response to herbicide IEP
IEP: Inferred from expression pattern
20553223 RGD
involved in response to hypoxia IDA
IDA: Inferred from direct assay
12692140 RGD
involved in response to hypoxia IEP
IEP: Inferred from expression pattern
21075155 RGD
involved in response to immobilization stress IEP
IEP: Inferred from expression pattern
11858766 RGD
involved in response to insecticide IEP
IEP: Inferred from expression pattern
21277943 RGD
involved in response to isolation stress IEP
IEP: Inferred from expression pattern
19893991 RGD
involved in response to light stimulus IEP
IEP: Inferred from expression pattern
21185915 RGD
involved in response to lipopolysaccharide IEP
IEP: Inferred from expression pattern
21239462 RGD
involved in response to metal ion IEP
IEP: Inferred from expression pattern
20224926 RGD
involved in response to nicotine IEP
IEP: Inferred from expression pattern
17437548 RGD
involved in response to nutrient levels IEP
IEP: Inferred from expression pattern
21364997 RGD
involved in response to organic cyclic compound IEP
IEP: Inferred from expression pattern
20951685 RGD
involved in response to peptide hormone IEP
IEP: Inferred from expression pattern
21129429 RGD
involved in response to pyrethroid IEP
IEP: Inferred from expression pattern
16229977 RGD
involved in response to salt stress IEP
IEP: Inferred from expression pattern
21113619 RGD
involved in response to steroid hormone IEP
IEP: Inferred from expression pattern
11883789 RGD
involved in response to xenobiotic stimulus IEP
IEP: Inferred from expression pattern
21396352 RGD
involved in response to zinc ion IEP
IEP: Inferred from expression pattern
20553223 RGD
involved in social behavior IEP
IEP: Inferred from expression pattern
15345906 RGD
involved in sphingolipid metabolic process IEP
IEP: Inferred from expression pattern
21076868 RGD
involved in terpene metabolic process IEP
IEP: Inferred from expression pattern
20934257 RGD
Cellular Component GO Annotation Evidence References Source
located in axon IDA
IDA: Inferred from direct assay
14681933 RGD
located in cytoplasmic vesicle membrane IDA
IDA: Inferred from direct assay
11943812 RGD
located in dendrite IDA
IDA: Inferred from direct assay
21362438 RGD
located in mitochondrion IDA
IDA: Inferred from direct assay
11943812 RGD
located in neuronal cell body IDA
IDA: Inferred from direct assay
21325515 RGD
located in perikaryon IDA
IDA: Inferred from direct assay
20434498 RGD
located in synaptic vesicle IDA
IDA: Inferred from direct assay
15496595 RGD
located in terminal bouton IDA
IDA: Inferred from direct assay
14681933 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

tyrosine 3-monooxygenase

  • tyrosine 3-hydroxylase

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (11)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-117287 Deucravacitinib Inhibitor 99.93% Unkown
HY-100754 Ritlecitinib Inhibitor 99.80% Yes
HY-N0394 L-Cystine 99.84% Unkown
HY-107916 Thyrotropin Inhibitor / Unkown
HY-B0976A Fenoterol hydrobromide Agonist 99.97% Unkown
HY-109520 Glatiramer acetate 98.0% Unkown
HY-B0976 Fenoterol Agonist 99.08% Unkown
HY-17002 Suplatast (Tosilate) Inhibitor 99.67% Unkown
HY-100754C Ritlecitinib tosylate Inhibitor 99.65% Yes
HY-100754A Ritlecitinib malonate Inhibitor / Unkown
HY-B0976AR Fenoterol hydrobromide (Standard) Agonist / Unkown
Inhibitory Antibodies (3)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P99025 Lebrikizumab Inhibitor 99.90% Unkown
HY-P99396 Spesolimab Inhibitor 99.10% Unkown
HY-P99256 Tildrakizumab Antagonist 99.46% Unkown

Clinical Phase

Bioactive Molecules (28)
Cat. No. Product Name Effect
Purity Phase
HY-Y0344D Sodium chloride, for cell culture Activator 99.9% Phase 4
HY-177835 Liposomal Iron / Phase 4
HY-124065 ARRY-502 Antagonist / Phase 4
HY-150298 Soquelitinib Inhibitor 99.98% Phase 3
HY-B2132 Tryptamine 99.89% Phase 3
HY-112137 Trehalose-6,6'-dibehenate Activator 99.92% Phase 3
HY-10535 Evofosfamide Inducer 98.0% Phase 3
HY-147410 Ulefnersen 99.22% Phase 3
HY-13743 Roquinimex Inhibitor 99.69% Phase 3
HY-160040 Cobitolimod Agonist 97.14% Phase 3
HY-160040A Cobitolimod sodium Agonist / Phase 3
HY-13743R Roquinimex (Standard) Inhibitor / Phase 3
HY-155950 TH9619 99.33% Phase 2
HY-148074 Zelnecirnon Inhibitor 99.71% Phase 2
HY-124573 (R)-Odafosfamide 98.52% Phase 2
HY-15342 Timapiprant Antagonist 98.12% Phase 2
HY-132828 Odatroltide Inhibitor 97.39% Phase 2
HY-17632 Tarloxotinib bromide Inhibitor 98.75% Phase 2
HY-114141 BI-671800 Antagonist 99.36% Phase 2
HY-118250 GSK2245035 99.79% Phase 2
HY-149040 Odafosfamide 99.06% Phase 2
HY-159507 Brezivaptan Antagonist 96.53% Phase 2
HY-16734 Amiselimod Modulator / Phase 2
HY-12284 NVP-QAV680 Antagonist / Phase 2
HY-103637 Vimirogant Inhibitor / Phase 2
HY-137131 DC-Chol hydrochloride 99.95% Phase 1
HY-139780 JNJ-61803534 Inhibitor 99.84% Phase 1
HY-159754 HS201 / Phase 1
Inhibitory Antibodies (7)
Cat. No. Product Name Effect
Purity Phase
HY-P99757 Nivatrotamab Inhibitor 99.00% Phase 2
HY-P991266 SM-17 Inhibitor 96.98% Phase 2
HY-P991510 CDX-1140 Agonist / Phase 2
HY-P991633 TQC2938 Inhibitor / Phase 2
HY-P991257 MK-1966 Inhibitor 96.17% Phase 1
HY-P99911 Efizonerimod alfa Agonist 98.57% Phase 1
HY-P991258 CNTO-5825 98.18% Phase 1

Pre-clinical Phase

Bioactive Molecules (257)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-153808 Complete Freund's adjuvant (CFA) / Unkown
HY-15826 SGC-CBP30 Inhibitor 99.83% Unkown
HY-P1240 MOG (35-55) mouse, rat 99.73% Unkown
HY-126360 Oxazolone 98.0% Unkown
HY-146244 Agatolimod 98.84% Unkown
HY-15417 ML-7 hydrochloride 99.88% Unkown
HY-P10408 Candidalysin Activator 99.81% Unkown
HY-150741C ODN 2216 sodium Agonist 98.57% Unkown
HY-125801 3-Oxo-5β-cholanoic acid Inhibitor 99.62% Unkown
HY-150741 ODN 2216 98.57% Unkown
HY-101092 QS-21-Api Activator 99.73% Unkown
HY-116961 TH1020 99.81% Unkown
HY-12776 GSK805 Inhibitor 99.83% Unkown
HY-147313 TH10785 Activator 99.93% Unkown
HY-P1240A MOG (35-55) TFA 99.68% Unkown
HY-113238A Lithocholic acid 3-sulfate disodium 99.93% Unkown
HY-138113 Pyrrothiogatain Inhibitor 98.61% Unkown
HY-143712 Allolithocholic acid 99.69% Unkown
HY-W009203 L-Cystine dihydrochloride 98.0% Unkown
HY-106224B Orexin A (human, rat, mouse) acetate Agonist 99.53% Unkown
HY-153808B Complete Freund's adjuvant (CFA, 1 mg/ml) / Unkown
HY-114360 Taurohyodeoxycholic acid Inhibitor 99.73% Unkown
HY-134771 YM-341619 Inhibitor 98.01% Unkown
HY-107413 SR11237 99.99% Unkown
HY-101392 Harmane Inhibitor 99.91% Unkown
HY-P2797A Chitinase, Streptomyces griseus / Unkown
HY-N2279 Kurarinone Activator 99.47% Unkown
HY-P1181A Pam2CSK4 TFA 99.46% Unkown
HY-N4084 Thonningianin A Inducer 99.73% Unkown
HY-123604 TH1834 99.79% Unkown
HY-12814 TH588 Inhibitor 99.20% Unkown
HY-N0440 Germacrone 99.76% Unkown
HY-P3993A (Gly14)-Humanin (human) acetate Inhibitor 99.86% Unkown
HY-N6636 Valencene Inhibitor 81.81% Unkown
HY-111818 TH34 Inhibitor 99.52% Unkown
HY-161296 TH6342 Inhibitor 99.15% Unkown
HY-W012732 Isoquinoline Inhibitor 99.58% Unkown
HY-W017982 CMIT/MIT (14.5% in water) 97.0% Unkown
HY-123604A TH1834 dihydrochloride 99.89% Unkown
HY-136065 bpV(phen) 98.0% Unkown
HY-W011220 Ciglitazone Agonist 99.74% Unkown
HY-125390 SM-360320 Agonist 99.41% Unkown
HY-N0885 Telocinobufagin 99.93% Unkown
HY-16734A Amiselimod hydrochloride Agonist 98.86% Yes
HY-16965 TH287 Inhibitor 98.99% Unkown
HY-119684 Maresin 2 Inhibitor 97.20% Unkown
HY-122630 TH-257 Inhibitor 98.36% Unkown
HY-W009356 L-Cystine hydrochloride 98.0% Unkown
HY-125209 TH5427 Inhibitor 99.92% Unkown
HY-N0723 Neomangiferin 99.80% Unkown
HY-150167 TH-Z93 Inhibitor 98.41% Unkown
HY-122818 BpV(phen) trihydrate 98.0% Unkown
HY-150217 CpG ODN 10101 Agonist 99.44% Unkown
HY-P2797 Chitinase, Serratia marcescens / Unkown
HY-W016174 Diphenyl sulfide 99.71% Unkown
HY-108522 PA452 Antagonist ≥99.0% Unkown
HY-150168 TH-Z145 Inhibitor 99.69% Unkown
HY-N4087 Platycodin D2 Inducer 99.84% Unkown
HY-N6066 Praeruptorin E 99.83% Unkown
HY-B0927 Hydrastine Inhibitor 99.57% Unkown
HY-126328 PKC-theta inhibitor 1 Inhibitor 99.45% Unkown
HY-N0594 Deacetylasperulosidic Acid 99.44% Unkown
HY-W010520 Methylisothiazolinone 99.43% Unkown
HY-Y0344J Sodium chloride, for molecular biology 99.97% Unkown
HY-145848 ERRγ agonist-1 Agonist 98.02% Unkown
HY-159102 PVP-037.2 Agonist 99.18% Unkown
HY-147410A Ulefnersen sodium 98.47% Unkown
HY-135909 TH1217 Modulator 99.20% Unkown
HY-W677684 Nurr1 agonist 2 Agonist 98.03% Unkown
HY-Y0344I Sodium chloride, meets analytical specification of Ph. Eur. BP USP, ≤0.00002% Al 99.99% Unkown
HY-114495 Caerulomycin A Inhibitor 98.0% Unkown
HY-N3138 Ombuoside 99.68% Unkown
HY-P10532 Myelin basic protein, MBP (68-86) 99.86% Unkown
HY-156466 QL-1200186 Inhibitor 99.95% Unkown
HY-146243 TH-Z835 99.58% Unkown
HY-164278 diABZI-V/C-Mal 99.28% Unkown
HY-N10534 Lewis X trisaccharide Inhibitor 99.91% Unkown
HY-N7501 Isoformononetin Inhibitor 99.47% Unkown
HY-P10109 G6PI 325-339 (human) Activator 95.00% Unkown
HY-W018829 10-Undecenal 98.36% Unkown
HY-120000 MS402 Inhibitor 98.36% Unkown
HY-151539 TH470 Inhibitor 99.62% Unkown
HY-173025 Nurr1 agonist 12 Agonist 99.62% Unkown
HY-15342A Timapiprant sodium Inhibitor 99.61% Unkown
HY-126037 (±)-ML 209 Antagonist 98.14% Unkown
HY-153663 TH-Z827 Inhibitor 95.12% Unkown
HY-N3388 Licoisoflavone B Inhibitor 99.46% Unkown
HY-N7512 Asimilobine 99.9% Unkown
HY-P3993 (Gly14)-Humanin (human) Inhibitor 95.39% Unkown
HY-101092B QS-21-Xyl 97.23% Unkown
HY-101392A Harmane hydrochloride Inhibitor 99.96% Unkown
HY-123468 HA-1004 Inhibitor 99.04% Unkown
HY-138115 7ß,27-Dihydroxycholesterol Activator 99.58% Unkown
HY-145809 FASN-IN-5 Inhibitor 99.98% Unkown
HY-179537 Selovoxolone Inhibitor 98.97% Unkown
HY-P1252 Parathyroid Hormone (1-34), bovine Agonist 99.88% Unkown
HY-W010243S Methylisothiazolinone-d3 hydrochloride 99.42% Unkown
HY-134113 Z-Gly-Pro-Arg-pNA 98.47% Unkown
HY-16668 Tyrphostin A1 Inhibitor 98.96% Unkown
HY-W783276 18:1(11-cis) PC ≥99.0% Unkown
HY-103637A Vimirogant hydrochloride Inhibitor 98.39% Unkown
HY-110295 SPL-334 Inhibitor 99.6% Unkown
HY-120574 TH1338 Inhibitor 98.77% Unkown
HY-120785 SR1555 Antagonist 99.69% Unkown
HY-142998 Vaxfectin 99.94% Unkown
HY-158694A TLR7 agonist 20 hydrochloride Agonist 99.86% Unkown
HY-P2299A Protein E7(43-62) TFA 98.85% Unkown
HY-113238F FITC-Lithocholic acid 3-sulfate 90.01% Unkown
HY-167692 JI069 Inhibitor 98.03% Unkown
HY-N0394S5 L-Cystine-13C6,15N2 98.4% Unkown
HY-164485 INI-4001 / Unkown
HY-135843 TH-263 Control 99.0% Unkown
HY-142938 RORγt agonist 3 Agonist 98.12% Unkown
HY-144002 RIBI-529 / Unkown
HY-145491 Resolvin D5 Inhibitor 98.3% Unkown
HY-153662 TH-Z816 Inhibitor 98.92% Unkown
HY-155219 TH9028 / Unkown
HY-174903 ITK-IN-6 Inhibitor 99.02% Unkown
HY-N10116A Calamenene / Unkown
HY-N9447 Norbergenin Inhibitor 98.31% Unkown
HY-P10463A ssK36 TFA Inhibitor 99.34% Unkown
HY-P1052A Myelin Basic Protein(87-99) TFA 99.23% Unkown
HY-P5333A Aβ1-14-εK-KKK-MvF5 Th acetate Inhibitor 99.93% Unkown
HY-W010243 Methylisothiazolinone hydrochloride 99.93% Unkown
HY-W017982A CMIT/MIT (2.0-2.5% in water) / Unkown
HY-W777360 Harman-13C2,15N Inhibitor 99.66% Unkown
HY-127023 Eicosapentaenoyl serotonin Inhibitor 99.0% Unkown
HY-138143 N-(p-Tosyl)-GPR-pNA acetate 99.9% Unkown
HY-B0976AS Fenoterol-d6 hydrobromide Agonist 98.02% Unkown
HY-P5333 Aβ1-14-εK-KKK-MvF5 Th 98.05% Unkown
HY-117287A Deucravacitinib (hydrochloride) Inhibitor / Unkown
HY-128353 ROR agonist-1 Antagonist / Unkown
HY-125444 TH251 Inhibitor / Unkown
HY-126252 A-9758 Inhibitor / Unkown
HY-130243 RORγt Inverse agonist 6 Antagonist 98.97% Unkown
HY-142806 RORγt inverse agonist 26 / Unkown
HY-187690 HGR4113 / Unkown
HY-101871 Trehalose 6-behenate / Unkown
HY-107413G SR11237 (GMP) / Unkown
HY-112348 HA-1004 hydrochloride Inhibitor / Unkown
HY-116890 CRTh2 antagonist 4 Antagonist / Unkown
HY-118250A GSK2245035 maleate / Unkown
HY-118428 Fluenetil / Unkown
HY-120225 NJK14047 Inhibitor / Unkown
HY-120785A SR1555 hydrochloride Antagonist / Unkown
HY-122349 Lotrifen / Unkown
HY-123568 PBI-1393 Inhibitor / Unkown
HY-125209A TH5427 hydrochloride / Unkown
HY-125693 L685818 Inhibitor / Unkown
HY-125801S 3-Oxo-5β-cholanoic acid-d4 / Unkown
HY-132851 Corixetan / Unkown
HY-134192 TH301 / Unkown
HY-135773 CRTh2 antagonist 3 / Unkown
HY-137292 PTB7-Th / Unkown
HY-139193 TH1760 Inhibitor / Unkown
HY-142703 RORγt inverse agonist 28 Inhibitor / Unkown
HY-142937 RORγt agonist 2 Agonist / Unkown
HY-143712R Allolithocholic acid (Standard) / Unkown
HY-143712S1 Allolithocholic Acid-d4 / Unkown
HY-143885 JAK1/TYK2-IN-3 Inhibitor / Unkown
HY-145577 Lafadofensine Inhibitor / Unkown
HY-149029 TH-6 96.64% Unkown
HY-155505 AHR agonist 4 Agonist / Unkown
HY-155680 BET BD2-IN-1 Inhibitor / Unkown
HY-157020 UniPR1449 Antagonist / Unkown
HY-158694 TLR7 agonist 20 Agonist / Unkown
HY-161255 3,4-DAA Inhibitor / Unkown
HY-162490 TF-S14 Inhibitor / Unkown
HY-162727 GCS-12 / Unkown
HY-163704 KRN7000 analog 1 / Unkown
HY-163801 Nurr1 agonist 9 Agonist / Unkown
HY-168207 TH023 Inhibitor / Unkown
HY-168347 TH152 Ligand / Unkown
HY-172692 DSPE-PEG1000-TH / Unkown
HY-172693 DSPE-PEG2000-TH / Unkown
HY-172694 DSPE-PEG5000-TH / Unkown
HY-175365 GCS-12–6 Ligand / Unkown
HY-175876 ADAM17-IN-1 Inhibitor / Unkown
HY-176262 TH10184 Ligand / Unkown
HY-176263 TH10184-octanedioic acid / Unkown
HY-176273 RORγt inverse agonist 35 Agonist / Unkown
HY-176535 KB-0118 Inhibitor / Unkown
HY-177277 HM5023507 Inhibitor / Unkown
HY-178240 rel-(1S,2R)-Dihydro bupropion Inhibitor / Unkown
HY-178721 Lithocholic amide-C2-N(didecane) Inhibitor / Unkown
HY-178966 STING agonist-48 Agonist / Unkown
HY-181739 GCB-27a Activator / Unkown
HY-181740 GCB-27b Activator / Unkown
HY-184214 Antileishmanial agent-44 / Unkown
HY-184273 TH-407a Inhibitor / Unkown
HY-186084 ACSL5-IN-4 / Unkown
HY-187480A DOPE-PEG2000-TH / Unkown
HY-187773A DPPE-PEG2000-TH / Unkown
HY-189091 Iso-Kaempferol / Unkown
HY-D3366 Th-TMR-S-Halo / Unkown
HY-D3367 Th-TMR-S-SNAP / Unkown
HY-N15846 VSA 1 / Unkown
HY-N16465 Cinnamtannin D1 Inhibitor / Unkown
HY-N18080 Parthenin Inhibitor / Unkown
HY-N18279 Bulbocapnine Antagonist / Unkown
HY-N20748 Lansiumamide B Inhibitor / Unkown
HY-N6636R Valencene (Standard) Inhibitor / Unkown
HY-N7501S Isoformononetin-d3 98.64% Unkown
HY-N7869 Celangulin VII / Unkown
HY-P10109A G6PI 325-339 (human) hydrochloride Activator / Unkown
HY-P10982 SjDX5-53 Inducer / Unkown
HY-P1181 Pam2CSK4 / Unkown
HY-P11838 DOTA-TH10 / Unkown
HY-P1252A Parathyroid Hormone (1-34), bovine TFA Agonist / Unkown
HY-P2299 Protein E7(43-62) / Unkown
HY-P2797B Chitinase / Unkown
HY-P2797C Chitinase,Trichoderma viride / Unkown
HY-P4389 (Asp28)-Glucagon (1-29) (human, rat, porcine) Activator / Unkown
HY-P4790 Acetyl-Exenatide Inhibitor / Unkown
HY-RS14467 TH Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W010520R Methylisothiazolinone (Standard) / Unkown
HY-W012732S2 Isoquinoline-15N / Unkown
HY-W016174S Diphenyl sulfide-d1 99.5% Unkown
HY-W683409 Dimorpholamine / Unkown
HY-W700834 Harman-d3 / Unkown
HY-W761985 Furathiocarb / Unkown
HY-W772717 L-Cystine disodium monohydrate / Unkown
HY-W795993 TJU103 Inhibitor / Unkown
HY-Y0344H Sodium chloride, United States Pharmacopeia (USP) Reference Standard / Unkown
HY-107413R SR11237 (Standard) / Unkown
HY-11054 TH-237A 98.08% Unkown
HY-112863 RORγt inhibitor 3 Inhibitor / Unkown
HY-119038 ML-7 / Unkown
HY-119684S Maresin 2 Inhibitor / Unkown
HY-123468A HA-1004 dihydrochloride Inhibitor / Unkown
HY-12814A TH588 hydrochloride Inhibitor / Unkown
HY-148014 TH7299 / Unkown
HY-157675 1,2-Dinervonoyl-sn-glycero-3-phosphocholine / Unkown
HY-164454 AJI-100 Inhibitor / Unkown
HY-164455 AJI-214 Inhibitor / Unkown
HY-16965A TH287 hydrochloride Inhibitor / Unkown
HY-174603 Human IL4R mRNA / Unkown
HY-174607 Human IL33 mRNA / Unkown
HY-174639 Human IL13 mRNA / Unkown
HY-174641 Human IL12B mRNA / Unkown
HY-174642 Human IL12A mRNA / Unkown
HY-175301 TH16 / Unkown
HY-175376 QPyN16Th Inhibitor / Unkown
HY-177300 TLR7/8 agonist 13 / Unkown
HY-183046 PAICS-IN-1 Activator / Unkown
HY-183448 ETMTC / Unkown
HY-188018 Mouse Tnf ASO Inhibitor / Unkown
HY-N0594R Deacetylasperulosidic Acid (Standard) / Unkown
HY-N0976 1,11b-Dihydro-11b-hydroxymedicarpin Activator / Unkown
HY-N3548 Catalpalactone Inhibitor / Unkown
HY-P10463 ssK36 Inhibitor / Unkown
HY-RS16660 Th Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23095 Th Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W018829R 10-Undecenal (Standard) / Unkown
HY-W130878 4-Octylphenol Activator / Unkown
HY-W745349 rel-(1S,2R)-Dihydro bupropion-d9 hydrochloride Inhibitor / Unkown
HY-W777138 rel-(1S,2R)-Dihydro bupropion-d9 Inhibitor / Unkown
Inhibitory Antibodies (15)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990121 Anti-Mouse IL-4 Antibody (11B11) Inhibitor 97.67% Unkown
HY-P99301 Lokivetmab Inhibitor 99.34% Unkown
HY-P990219 Anti-Mouse IL-2 Antibody (JES6-1A12) Inhibitor 99% Unkown
HY-P990145 Anti-Mouse VISTA Antibody (13F3) Inhibitor ≥95.0% Unkown
HY-P991761 Anti-Mouse CXCL10 Antibody (1F11) Inhibitor 97.564% Unkown
HY-P990208 Anti-Mouse IL-9 Antibody (9C1) Inhibitor 95.00% Unkown
HY-P990124 Anti-Mouse GITR Antibody (DTA-1) 98.47% Unkown
HY-P990796 Anti-Mouse IL-2 Antibody (S4B6-1) Inhibitor 96.97% Unkown
HY-P992132 Solaprubart Inhibitor 99.59% Unkown
HY-P990177 Anti-Mouse Notch4 Antibody (HMN4-14) Inhibitor / Unkown
HY-P990206 Anti-Mouse Jagged 2 Antibody (HMJ2-1) Inhibitor / Unkown
HY-P991274 BMS-986010 Inhibitor / Unkown
HY-P991380 TXB4 Inhibitor / Unkown
HY-P991467 RG-7258 Inhibitor / Unkown
HY-P990252 Anti-Mouse Delta-like protein 4/DLL4 Antibody (HMD4-2) 95.98% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Th NCBI NCBI:7054